CD4 and lupus nephritis: treated mice with lupus nephritis using DPSCs; the mice showed a reduction in IgG and IgM deposition in the glomeruli, a significant decrease in the number of CD4+ T cells that produce IFN-γ, and a reduction in perivascular inflammatory infiltrates (91).